Partnering with Internal Stakeholders to Maximize External Alliances

Many alliance managers have observed that although alliances by definition involve working with external partners, it's the internal work that takes up most of their time and effort. This includes securing alignment of internal research and development leaders and other stakeholders in order to execute on an innovation strategy that relies on partnering.

This session will explore:


Patrick Gliha
Executive Director, Global Alliances

Patrick Gliha is an executive director and member of the BMS Global Alliances Leadership Team. In this role, Patrick is responsible for leading a team of seven alliance managers and overseeing a portfolio of external collaborations that are cross-therapeutic, cross-modality, and cross-phases of development and commercialization.

Patrick joined BMS in 2019 through the acquisition of Celgene. Prior to joining the global alliances team, he began his career working in global government affairs & policy at Celgene and Amgen, working on access and reimbursement for the in-line portfolio and late-stage pipeline.


Janeen Doyle
Senior Vice President, Global Alliances
Bristol Myers Squibb

Janeen Doyle is the senior vice president of global alliances at Bristol Myers Squibb (BMS). In this role, Janeen is responsible for managing a portfolio of strategic collaborations with internal and external partners, spanning from early drug discovery to commercialization.

Janeen leads a group of alliance leaders who manage collaborations, governance structures and embed partnering best practices across Bristol Myers Squibb. External partnerships play a critical role in helping BMS carry out its mission of discovering, developing and delivering innovative medicines that help transform the lives of patients through science.

Prior to the BMS acquisition of Celgene, Janeen worked at Celgene for 10 years holding various positions of increasing responsibilities in business development, alliance management & integration, project leadership and medical affairs. Before joining Celgene in 2009, Janeen held a range of roles in clinical research for multiple biotechnology companies.

Janeen holds bachelor's degree in biology and a master's degree in business administration.

Emma Lees
Senior Vice President, Research & Early Development & BMS Boston Site Head
Bristol Myers Squibb